搜尋結果
Search drug, interactions and image information in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia, India & USA.
MIMS.com is the leading online source of drug information, interactions, images, dosage and side effects for healthcare professionals in Malaysia and beyond. Whether you are looking for the latest medical news, updates on clinical guidelines, or comprehensive drug databases, MIMS.com has it all. Join millions of users who trust MIMS.com as their essential medical reference.
Search company information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India.
Dosage/Direction for Use. Adult & ped patient ≥6 yr Initially 30 mg once daily in the morning, may be adjusted in increments of 10 or 20 mg at approx wkly intervals. Max: 70 mg once daily. Patient w/ severe renal impairment (GFR 15 to <30 mL/min/1.73 m2) Max: 50 mg once daily. Patient w/ ESRD (GFR <15 mL/min/1.73 m2) Max: 30 mg once daily.
Description. View Silmazin description for details of the chemical structure and excipients (inactive components). MIMS Class. Topical Antibiotics. ATC Classification. D06BA01 - silver sulfadiazine ; Belongs to the class of topical sulfonamides used in the treatment of dermatological diseases. Regulatory Classification. P 1. Presentation/Packing.
Dosage/Direction for Use. SC Prevention of skeletal related events in adults w/ advanced malignancies involving bone 120 mg single dose once every 4 wk into thigh, abdomen or upper arm. Giant cell tumour of bone 120 mg single dose once every 4 wk into thigh, abdomen or upper arm, w/ additional 120 mg doses on days 8 & 15 of 1st mth of therapy ...
Dosage/Direction for Use. 0.5 mg (0.05 mL) as a single intravitreal inj. The interval between 2 doses injected into the same eye should be at least 4 wk. Initiate w/ 1 inj per mth until max visual acuity is achieved &/or there are no signs of disease activity. In wet AMD, DME, PDR & RVO, initially, ≥3 consecutive, mthly inj may be needed.
